Drugs / anti-CEAxanti-DTPA bispecific antibody
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00467506 | May 2004 → Jan 2011 | thyroid cancer | Nantes University Hospital | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | anti-CEAxanti-DTPA bispecific antibody | “using anti-CEAxanti-DTPA bispecific antibody” NCT00467506 ↗ |